Podcasts about Western University

In this episode, we discuss Physiotherapy within the Paediatric population. We explore: Cervical manual therapy in infants, children and adolescents: yes or no?Evidence based treatment for paediatric conditions e.g. colic, torticollisAppropriate manual therapy technique selection for paediatrics Shared decision making within the paediatric realmThe collaboration of the Paediatric Spinal Task Force

In this empowering episode of Success Unlocked, Dr. Adrienne Shnier sits down with Katherine Switt, a fourth-year Medical Sciences student at Western University and AYG client, to unpack her transformation from stress and self-doubt to confidence and clarity.Katherine shares how she went from burnout and frustration with “big box” prep programs to finding focus, balance, and joy in her MCAT prep through Apply Yourself Global's one-on-one coaching and mindset work. From the blue couch moment that changed everything to mastering efficient scheduling and reframing success, Katherine's story shows that it's not just about studying harder; it's about studying smarter and believing you can do hard things.What You'll Learn✔ Why mindset, not just content, makes or breaks your MCAT prep ✔ How personalized coaching and structure reduce stress and burnout ✔ Why “balance” is the real key to long-term academic success ✔ The difference between memorizing and actually learning ✔ How to turn anxiety into confidence and reclaim joy in the process ✔ The power of defining your North Star and creating a life beyond the goal ✔ Why the AYG approach helps students achieve more with less overwhelmMastering Academic Applications: From Scratch to Submission is now open for you to complete your applications in 12-weeks! With live coaching, you develop your applications & gain insights into your applications processes like never before. Join us now using this link to enroll!Connect with Adrienne! Looking for support with your graduate or professional school applications? Connect with us at Apply Yourself Global™! Email me personally at adrienne@applyyourselfglobal.com. You can also DM me on Instagram @applyyourselfglobal. Ask the Expert Have any questions on applications, success, test prep, and more? Send your questions us, or you can submit an audio file via Instagram DM and we can feature you on the podcast! Work with Adrienne

In this week's episode, hosts Milan Mammen and Kelly Wang interview Denise Bedard, a PhD candidate in Health and Rehabilitation Sciences (Health and Aging). Denise shares with us her immense professional and academic experience in long term care, including reimagining person-centered care in small home service areas. Denise also kindly shares the difficult lessons learned about long term care through the COVID pandemic and its many impacts, especially on older adults in long term care; please consider this a content warning if this is a particularly sensitive subject for you. Denise is part of the Caregiving Research (CARE) Lab at Western University.   Recorded on Tuesday, November 18, 2025. Produced by kirstyn seanor. Theme song provided by FreeBeats.io (Produced by WhiteHot).

Mauricio Di Bartolomeo is the co-founder and CSO of Ledn, a leading provider of bitcoin-backed loans. He found Bitcoin during hyperinflation in Venezuela and believes in the future of the digital economy. He has an MBA from the Richard Ivey business school at Western University.Mauricio Di Bartolomeo, the co-founder and CSO of Ledn, recently joined the Bitcoin.com News Podcast to talk about the market.Growing up in Venezuela and experiencing hyperinflation, bank collapses, and capital controls firsthand, Mauricio witnessed the disastrous consequences of a failing government and currency. His family eventually found a solution and "a beam of light" in Bitcoin mining, which allowed his brother to escape the country with his wealth intact on a hardware wallet, an experience that cemented their conviction in Bitcoin as a tool for economic freedom and survival.Mauricio explains how this experience led to the founding of Ledn, a company built to solve the problem faced by Bitcoin miners and holders: the need for financing without having to sell their Bitcoin. He delves into the core value proposition of Bitcoin-backed loans, especially for the emerging world, highlighting that Ledn offers the same rates and terms to clients in Latin America as those in Europe or North America. This capability is providing financial inclusion, giving many in the region their first-ever loan approval, which is a massive, transformative opportunity that traditional banks have historically denied.The discussion pivots to Ledn's decision to transition to a Bitcoin-only company after a period of supporting Ethereum during the Celsius bankruptcy transition. Mauricio outlines the move as a commitment to simplicity and transparency, emphasizing the company's deep belief in the long-term viability and investment case of Bitcoin. The conviction is rooted in the belief that the future of Bitcoin-backed loans is a multi-trillion-dollar opportunity, and Ledn aims to win by focusing on doing Bitcoin-backed loans better than anyone else, adhering to the principle that "the best restaurants have the smallest menus."A crucial component of Ledn's commitment to transparency is its pioneering and ongoing Proof of Reserves protocol. Mauricio details this process, explaining that an independent CPA verifies Ledn holds all the assets it owes its clients by looking at both the asset and liability sides every six months, a cadence the company is moving to monthly. He stresses the vital importance of Proof of Reserves—something all failed crypto lenders like FTX lacked—as a requirement clients should demand, ensuring a company is honestly reporting its liabilities and protecting client assets.The episode also covers the concept of the "new carry trade," which is the strategy of borrowing a weak, constantly-debased currency (like the US Dollar) against a hard, appreciating asset with a finite supply (Bitcoin). Mauricio illustrates this with a client anecdote who was able to buy a house without selling his Bitcoin, which then appreciated fivefold. He explains that this strategy is tax-beneficial and mirrors how the world's wealthy manage their assets, allowing Bitcoin holders to "go short weak dollars and maintain your strong Bitcoin," ultimately helping them grow their net wealth over time.Finally, Mauricio addresses the looming entry of traditional banks into the Bitcoin services space. He argues that Bitcoin-native companies like Ledn have a massive advantage because the banks' fractional reserve model is incompatible with Bitcoin's ethos of full reserves. He cautions users to be skeptical of banks' intentions and collateral practices. Ledn, a regulated business built to operate 24/7 in the volatile crypto market, is focused on building a "Fort Knox" that is designed to outlive its founders and their children, a powerful statement on their commitment to generational wealth and long-term security.To learn more about the company visit Ledn.io, and follow the team on X.

Maynooth University has joined an international space science mission with the successful launch of Mauve, a small ultraviolet telescope developed by UK-based company Blue Skies Space. The satellite, which was launched aboard SpaceX's Transporter-15 on November 28th 2025 at 18:18 GMT, marks the beginning of a three-year mission to study how stars behave and how their activity influences the habitability of distant exoplanets. With funding from Research Ireland, Maynooth University became a member of the Mauve Science Programme in August 2025. A research team from the Department of Physics, led by Dr Emma Whelan, will use Mauve to investigate how stars and planets form, focusing on a class of young stars known as Herbig Ae/Be stars. Herbig Ae/Be stars are in a critical stage of development before they begin hydrogen fusion and become main sequence stars, like our Sun. Dr Whelan's team will study their brightness over long periods to identify variability and search for signs of early planet formation. "I am very excited to be embarking on this adventure with Mauve and eagerly anticipate the research opportunities it will bring," Dr Whelan said. "Until now, my work has primarily relied on ground-based eight-metre-class telescopes, so Mauve represents an exciting new direction for me. Its monitoring capabilities will provide a fresh window on star formation and offer valuable new insights." The group plans to build light curves for a large sample of these stars, tracking how their brightness changes daily for up to three months. Comparing this data to observations of less massive stars may provide key insights into whether larger young stars form and develop planets in the same way as Sun-like stars. The importance of the Mauve Space Programme is not only in its scientific goals but also in how it represents a new, faster, and more collaborative approach to doing space science. Designed and built in under three years, Mauve is a small, suitcase-sized satellite, weighing around 18kg, and equipped with a 13 cm telescope that observes in ultraviolet and visible light (200-700 nm). Its compact design and commercial access model allow research institutions worldwide to subscribe to the science programme, gaining direct access to space-based data without relying on highly competitive national telescope allocations. Research institutions worldwide have already secured subscriptions to access data collected by Mauve. These include Boston University, Columbia University, INAF's Osservatorio Astrofisico di Arcetri, Konkoly Observatory, Kyoto University,National Astronomical Observatory of Japan, Maynooth University, Rice University, Vanderbilt University, and Western University. Speaking about the launch, Professor Giovanna Tinetti, Chief Scientist and Co-founder of Blue Skies Space said: "Mauve will open a new window on stellar activity that has previously been largely hidden from view. By observing stars in ultraviolet light, wavelengths that can't be studied from Earth, we'll gain a much deeper understanding of how stars behave and how their flares may impact the environment of orbiting exoplanets. Traditional ground-based telescopes just can't capture this information, so a satellite like Mauve is crucial for furthering our knowledge." "Our vision is to make space science data as accessible as possible," said Dr Marcell Tessenyi, CEO and Co-founder of Blue Skies Space. "Mauve will undergo commissioning before delivering datasets to scientists in early 2026 and serve as a springboard to launch a fleet of satellites addressing the global demand for space science data." You can learn more about Dr Emma Whelan's MAUVE involvement here. See more stories here.

“The Golden Generation: How Canada Became a Basketball Powerhouse” Get your copy today! We sit down with the author of this recently released book and discuss how and why he decided to write it, the process and all in between. Oren, a Western University grad and Toronto native, loved sports growing up as a kid and basketball started to really catch his eye when he attended powerhouse Oakwood High School. Following his love for sport and media, he finished his degree and hit the ground running. Since then Oren has been a freelance writer and ventured into many avenues so far in his young career. We appreciate Oren's time as he talks about his career to this point and how excited he is for the 2028 Olympics, the book has it all, from history to current players and it's an easy, light read worth checking out!  If you're a hoop head this episode is a must! Oren Weisfeld  - Guest https://www.orenweisfeld.com https://x.com/OrenWeisfeld https://www.instagram.com/orenweisfeld Aaron Mitchell - Host Instagram: https://www.instagram.com/a_a_mitch/ Instagram: https://www.instagram.com/ahoopsjourney/ Website: https://www.ahoopsjourney.com/

In this NBN episode, host Hollay Ghadery speaks with Treena Orchard about her memoir, Sticky, Sexy, Sad: Swipe Culture and the Darker Side of Dating Apps (Aevo, U Toronto Press, 2024).  Jane Goodall meets Carrie Bradshaw in Sticky, Sexy, Sad – an insightful, empowering memoir by an anthropologist who lays her own life bare as she explores the cultural matrix of digital courtship. Lifelong luddite Treena Orchard was a newly sober woman coming off a much-needed break from relationships, reluctantly taking the digital plunge by downloading a dating app. Instead of the fun, easy experiences advertised on swiping platforms, she discovered endless upkeep, ghosting, fleeting moments of sexual connection, and a steady flow of misogyny. In Sticky, Sexy, Sad, Orchard uses her skills as both an anthropologist who studies sexuality and a sex-positive feminist to explore what it feels like to want love while also resisting the addictive pull of platforms designed to make us swipe-dependent. She asks important questions for those searching for love in the modern era: What are the social and human impacts of using dating apps? How can we maintain our integrity and warm-blooded desire for intimacy while swiping? Can we resist some of the problematic aspects of swipe culture? Is love on dating apps even possible? Revealing how dating apps are powerful social and sexual technologies that are radically transforming sexuality, relationships, and how we think about ourselves, this remarkable book cracks the code of modern romance. Told with humor and vulnerability, Sticky, Sexy, Sad is a riveting and inspiring guide to staying true to ourselves amid the digitization of love in the twenty-first century. Treena Orchard is an anthropologist and associate professor in the School of Health Studies at Western University. She researches and engages in activist debates about sexuality, gender, and health among diverse cultural and digital communities. Deeply committed to public scholarship, she regularly writes for and is featured in leading online publications, including Cosmopolitan, Men's Health, and The Conversation. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this NBN episode, host Hollay Ghadery speaks with Treena Orchard about her memoir, Sticky, Sexy, Sad: Swipe Culture and the Darker Side of Dating Apps (Aevo, U Toronto Press, 2024).  Jane Goodall meets Carrie Bradshaw in Sticky, Sexy, Sad – an insightful, empowering memoir by an anthropologist who lays her own life bare as she explores the cultural matrix of digital courtship. Lifelong luddite Treena Orchard was a newly sober woman coming off a much-needed break from relationships, reluctantly taking the digital plunge by downloading a dating app. Instead of the fun, easy experiences advertised on swiping platforms, she discovered endless upkeep, ghosting, fleeting moments of sexual connection, and a steady flow of misogyny. In Sticky, Sexy, Sad, Orchard uses her skills as both an anthropologist who studies sexuality and a sex-positive feminist to explore what it feels like to want love while also resisting the addictive pull of platforms designed to make us swipe-dependent. She asks important questions for those searching for love in the modern era: What are the social and human impacts of using dating apps? How can we maintain our integrity and warm-blooded desire for intimacy while swiping? Can we resist some of the problematic aspects of swipe culture? Is love on dating apps even possible? Revealing how dating apps are powerful social and sexual technologies that are radically transforming sexuality, relationships, and how we think about ourselves, this remarkable book cracks the code of modern romance. Told with humor and vulnerability, Sticky, Sexy, Sad is a riveting and inspiring guide to staying true to ourselves amid the digitization of love in the twenty-first century. Treena Orchard is an anthropologist and associate professor in the School of Health Studies at Western University. She researches and engages in activist debates about sexuality, gender, and health among diverse cultural and digital communities. Deeply committed to public scholarship, she regularly writes for and is featured in leading online publications, including Cosmopolitan, Men's Health, and The Conversation. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

In this NBN episode, host Hollay Ghadery speaks with Treena Orchard about her memoir, Sticky, Sexy, Sad: Swipe Culture and the Darker Side of Dating Apps (Aevo, U Toronto Press, 2024).  Jane Goodall meets Carrie Bradshaw in Sticky, Sexy, Sad – an insightful, empowering memoir by an anthropologist who lays her own life bare as she explores the cultural matrix of digital courtship. Lifelong luddite Treena Orchard was a newly sober woman coming off a much-needed break from relationships, reluctantly taking the digital plunge by downloading a dating app. Instead of the fun, easy experiences advertised on swiping platforms, she discovered endless upkeep, ghosting, fleeting moments of sexual connection, and a steady flow of misogyny. In Sticky, Sexy, Sad, Orchard uses her skills as both an anthropologist who studies sexuality and a sex-positive feminist to explore what it feels like to want love while also resisting the addictive pull of platforms designed to make us swipe-dependent. She asks important questions for those searching for love in the modern era: What are the social and human impacts of using dating apps? How can we maintain our integrity and warm-blooded desire for intimacy while swiping? Can we resist some of the problematic aspects of swipe culture? Is love on dating apps even possible? Revealing how dating apps are powerful social and sexual technologies that are radically transforming sexuality, relationships, and how we think about ourselves, this remarkable book cracks the code of modern romance. Told with humor and vulnerability, Sticky, Sexy, Sad is a riveting and inspiring guide to staying true to ourselves amid the digitization of love in the twenty-first century. Treena Orchard is an anthropologist and associate professor in the School of Health Studies at Western University. She researches and engages in activist debates about sexuality, gender, and health among diverse cultural and digital communities. Deeply committed to public scholarship, she regularly writes for and is featured in leading online publications, including Cosmopolitan, Men's Health, and The Conversation. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/popular-culture

Beyond the MD: Why a Johns Hopkins MBA Chose Medical Sales U (ft. Dr. Kevin Maggisano)What does it take to bridge the gap between clinical expertise and business execution? In this episode, we sit down with Dr. Kevin Maggisano, a professional who embodies the intersection of high-level medical vision and elite business strategy.Despite earning his MD from Western University and completing an MBA from Johns Hopkins, Dr. Maggisano believes that real leadership requires more than just degrees. It requires business clarity and strategic communication. That is exactly why he chose to enroll in Medical Sales U.In this episode, we cover:The Power of Continuous Growth: Why Dr. Maggisano believes leaders at every level, even those with MDs and MBAs, can still sharpen their business strategy and grow.Strategic Communication: How to move beyond clinical knowledge to master the art of communicating value and driving measurable results.Validating the Process: How Dr. Maggisano's experience reinforces the credibility and direction of Medical Sales U, proving that our focus on leadership and results works for top-tier professionals.Building a Career: Insights on how to build a rewarding career inside the medical sales world by combining medical authority with sales acumen.Dr. Maggisano's story is a powerful reminder that future leaders can trust the process. His voice amplifies our mission to help professionals identify their strengths and succeed in the competitive world of medical sales.About Dr. Kevin Maggisano: Dr. Maggisano combines deep medical insight with rigorous business training. He holds an MD from Western University and an MBA from Johns Hopkins University. He joined Medical Sales U to further strengthen his leadership skills and refine his approach to business strategy.Learn more about coaching and career support at https://medicalsalesu.com/

Nick Thran joins the podcast LIVE at the Fraser Valley Writers' Festival in Abbotsford, BC, to chat about his new book Existing Music. Andrew wonders about time in music and the passage of time. It's a joyous return to in-person Page Fright!--Nick Thran's newest collection of poems is Existing Music. His previous books include the mixed-genre collection If It Gets Quiet Later On, I Will Make a Display (2023) and three previous collections of poems. Earworm (2011) won the 2012 Trillium Book Award for Poetry. His poems have been anthologized in Best Canadian Poetry and The Next Wave: An Anthology of 21st Century Canadian Poetry. Thran lives on unceded Wolastoqey territory (Fredericton, NB), where he works as an editor and bookseller.--Andrew French is a poet from North Vancouver, British Columbia. They have published three chapbooks, most recently Buoyhood (Alfred Gustav Press, 2025). Andrew holds a BA in English from Huron University College at Western University and an MA in English from UBC. They have hosted this podcast since 2019.

As we are rattled by the news every day with something astonishing, often horrifying—scandals, political collisions and war—it becomes hard to keep our connection to the concept of international law. Why is the rules-based order under so much strain? Joining Jeremy and Louise are former ambassadors Sabine Nolke, a Visiting Fellow at Western University and practitioner of international law, and Jon Allen, Senior Fellow at the University of Toronto's Bill Graham Centre for Contemporary International History and a Distinguished Senior Fellow at the Canadian International Council.

#moldjacked Learn more here - https://moldjacked.com/Pejman Katiraei (Dr. K) was born in Iran, and he and his parents had to flee their home to avoid persecution. His parents instilled in him a strong sense of morals, ethics and values. Dr. K was the curious child who always wanted to know how everything works. It was this curiosity that encouraged Dr. K to explore and later specialize in holistic and integrative medicine.After UCLA, he went onto obtaining his osteopathic medical degree from Western University of Health Sciences. He then started his pediatric residency at Loma Linda University. Early in education and training, Dr. K questioned why some diseases “just happen” without any conventional explanation? Why would some patients die of horrible infections and others never have any problems?Despite his clinical proficiency and education, Dr. K believes he can do more to help his patients. In May of 2012, he started a second fellowship in endobiogeny, which is a sophisticated study of how hormones and our nervous system interact with one another to control health and disease. This endless desire for professional growth and learning is a testament to Dr. K's desire to help the sick regain their health and his commitment to keeping children healthy by identifying and treating subtle imbalances as early as possible before they ever turn into a disease. Dr. K hopes he can serve the children in Wholistic Kids and Families with the same mindset as the Chinese practitioners thousands of years ago.Join us as Dr. O and Dr. K dive into mold, mycotoxins, and their surprising connections to the health of you and your children!For more information on Dr. K, visit: https://wholistickids.comGluten Sensitive?  Take the quiz & Join Our Community ▶https://www.glutenfreesociety.org/gluten-sensitivity-intolerance-self-test/Get my quick start guide on going gluten free: https://www.glutenfreesociety.org/how-to-go-gluten-free/Nutritional Crash Courses Playlist: https://www.glutenfreesociety.org/nutritionGet Gluten Free Supplements: https://www.glutenfreesociety.org/shop-home/No Grain No Pain the Book: https://www.glutenfreesociety.org/NoGrainNoPainGlutenology Masterclass (Ultimate Guide): https://glutenology.net/registrationTo connect with Dr. Osborne visit:On the web: https://drpeterosborne.com/Facebook: https://www.facebook.com/DoctorPeterOsborne/TikTok: https://www.tiktok.com/@drpeterosborneInstagram: https://www.instagram.com/drosborneTwitter: https://twitter.com/glutenologyPinterest: https://www.pinterest.com/docosborne/Podcast:Apple Podcasts: https://podcasts.apple.com/us/podcast/dr-osbornes-zone/id1706389688?uo=4Spotify: https://open.spotify.com/show/4Zdf07GgpRAVwlSsYvirXTAmazon Music/Audible: https://music.amazon.com/podcasts/20d71b2e-3554-4569-9d5b-4259785cdc94Google Podcasts: https://www.google.com/podcasts?feed=aHR0cHM6Ly93d3cuc3ByZWFrZXIuY29tL3Nob3cvNTkwNjcwNC9lcGlzb2Rlcy9mZWVkiHeart Radio: https://iheart.com/podcast/119388846Dr. Peter Osborne is one of the most sought after alternative and nutritional experts in the world. A Diplomate with the American Clinical Board of Nutrition, a graduate of Texas Chiropractic College, and a doctor of pastoral science, Dr. Osborne is one of the world's leading authorities on gluten, nutrition, and natural health.   He is the founder GlutenFreeSociety.org, one of the world's largest informational sites on gluten sensitivity.  In addition, he is the author of the best selling book, No Grain No Pain, published by Touchstone (Simon & Schuster).  His work has been featured by PBS, Netflix, Amazon, Fox, U.S. News, Ney York Post, and many other nationally recognized outlets.For collaborations please email: glutenology@gmail.comAny information on diseases, treatments, nutrition, or other health related topics from this channel are for educational purposes only, and should not be considered a substitute for advice provided by your doctor or healthcare provider.  Bottom line...if you have health issues, you should always seek professional medical guidance.Products and supplements discussed in this video have not been evaluated by the FDA.  They are not intended to treat, cure, or diagnose.  Dr. Osborne is an Amazon affiliate, and many earn from qualifying purchases.   For more information, visit us at https://www.glutenfreesociety.org/  or call 281-903-7527

Welcome to Episode 281 of Autism Parenting Secrets.If you're a parent who's heard about Leucovorin, folinic acid, or calcium folinate—and you're confused—you're not alone. There's a lot of conflicting information right now, especially in the wake of the Leucovorin case and increased media attention.This week's guest returns to the podcast to help clarify what really matters. Nicole Rincon is a board-certified Physician Assistant, a microbiologist by training, and a deeply committed parent who's been supporting children with autism—including her own triplets—for over a decade.She brings both clinical and lived experience to this topic—and today, we dig into the nuances of folate metabolism, pharma vs supplement forms, and the specific use cases for Leucovorin and related supports.The secret this week is…Clarify The Leucovorin ConfusionYou'll Discover:Why Leucovorin Is Suddenly Getting National Attention (4:23)Signs of Cerebral Folate Deficiency (8:11)How To Know If Pharma Or Supplement-Based Support Is Right For Your Child (12:15)Why Supporting The Folate Pathway Can Improve Speech, Focus, and Behavior (18:28)What Parents Should Ask Before Starting Leucovorin (24:17)Whether Leucovorin Is A Short-Term Fix Or Long-Term Support (33:13)About Our Guest:Nicole Rincon, MS, PA-C, is a board-certified Physician Assistant with a background in microbiology and genetics. She received her Master's Degree from Western University of Health Sciences and has been working with children with autism—including her own triplets—for over a decade. Nicole offers functional and integrative care, combining deep clinical knowledge with personal insight.

How would you feel if you could no longer smell your favourite scent? Anosmia is a partial or full loss of smell. While usually a temporary symptom of an illness like a cold or sinus infection, more serious medical issues like a brain injury or diabetes could cause anosmia. On today's episode of the DocTalks Podcast, Dr. Leigh Sowerby, Division Head of Rhinology and Skull Base Surgery at St. Joseph's Health Care London and Associate Professor in the Department of Otolaryngology Head and Neck Surgery at Western University, joins to discuss anosmia. He chats with host, Mandi Fields, about causes, impact on lifestyle and treatments.  Note: The content of St. Joseph's DocTalks Podcast is for informational purposes only. The material is not intended for and should not be used as a substitute for direct medical advice from a licensed health care practitioner. Brought to you in partnership with St. Joseph's Health Care Foundation. Produced by The Pod Cabin and Emily Mackey.

In this special Complex Care Journal Club podcast episode, host Dr. Kilby Mann interviews presenters of posters and oral abstracts relevant to the care of children with medical complexity at the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 79th Annual Meeting, October 15-18, 2025, in New Orleans, Louisiana. Speakers describe their study findings and implications for practice. Dr. Francisco Valencia also discusses the role of the Complex Care Committee and the profound impact of mentorship in the field of complex care. SPEAKERS Laura Brunton, PT, PhD, Associate Professor, School of Physical Therapy, Western University, London, Ontario, Canada Caitlin Cassidy, MD, Associate Professor, Department of Physical Medicine and the Department of Rehabilitation and Pediatrics, Western University, London, Ontario, Canada Susan Gibb, MBBS, FRACP, Medical Lead, Complex Care Hub, Royal Children's Hospital, Melbourne, Australia Francisco Valencia, MD, Pediatric Orthopedic Surgeon, Children's Clinics For Rehabilitative Services, Tucson, Arizona Simran Prakash, BA, Medical Student, University of Miami Miller School of Medicine Karen Pratt, BA, MSc, PhD Candidate, Western University School of Health Sciences, London, Ontario, Canada Claire Wallace, PhD, Pediatric Psychologist, Ranken Jordan Pediatric Bridge Hospital, Maryland Heights, Missouri Esther Yap, BPharm, MD, Physician, Royal Children's Hospital, Melbourne, Australia HOST Kilby Mann, MD, Assistant Professor, Pediatric Rehabilitation Medicine, Children's Hospital Colorado DATE Initial publication date: November 11, 2025. RESOURCES REFERENCED - American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 29th Annual Meeting, October 15-18, 2025, New Orleans, LA. https://www.aacpdm.org/events/2025/program - American Academy for Cerebral Palsy and Developmental Medicine (AACPDM), www.aacpdm.org/ - AACPDM Complex Care Committee (www.aacpdm.org/about-us/committees/complex-care) TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/bgmft56r8ksk85qxbthvzs/CCJCP_AACPDM_Transcript_11-4-25‌ Clinicians across healthcare professions, advocates, researchers, and patients/families are all encouraged to engage and provide feedback! You can recommend an article for discussion using this form: https://forms.gle/Bdxb86Sw5qq1uFhW6. Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Valencia F, Brunton L, Cassidy C, Gibb S, Prakash S, Pratt K, Wallace C, Yap E, Mann K. Practice-Changing Research in Complex Care at the AACPDM Annual Meeting 2025. 11/2025. OPENPediatrics. Online Podcast.‌ https://soundcloud.com/openpediatrics/practice-changing-research-in-complex-care-at-the-aacpdm-annual-meeting-2025.

In this week's episode, hosts Ryan Baxter and Mark Ambrogio interview Meghan Voll, a PhD candidate in Media Studies here at Western University. GradCast listeners will recognize Meghan's voice, as Meghan served as a long-time host and Social Media Manager for this show.  This is Meghan's second time with us as a guest, as she approaches the conclusion of her doctorate, for those interested, Meghan's first episode, as a guest, can be heard here. Meghan studies the interaction between economic value and values on mobile dating platforms such as Tinder, Hinge, and Coffee Meets Bagel, drawing from the political economy of communication, mobile dating studies (MDS) and critical data studies (CDS). Ryan and Mark engage with Meghan on these ideas, asking about the intersection between so-called "soft values" (such as honesty and loyalty) and economic value ($). They also ask Meghan about her field research, interviewing human subjects, and the steps involved in obtaining ethics approval. Recorded on Tuesday, November 5, 2025 Produced by Mark Ambrogio and Kelly Wang Theme song provided by FreeBeats.io (Produced by WhiteHot)

It's YOUR time to #EdUpPCO In this episode, YOUR guest is Jamie Merisotis, President and CEO of the Lumina Foundation YOUR host is Amrit Ahluwalia⁠⁠, Executive Director of Continuing Studies at Western University in London, Ontario, Canada.Some key questions we tackle:·      Why has the Lumina Foundation set a new target of 75% postsecondary attainment by 2040?·      How has the technological evolution shifted what it takes to be competitive in the labour market?·      What role can PCO units play in helping their home institutions support regional workforce transformation?Listen in to #EdUp! Thank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Join YOUR EdUp community at ⁠⁠⁠⁠The EdUp Experience⁠⁠⁠⁠!We make education YOUR business!

U.S. President Donald Trump is clear and consistent: he wants Canadian auto sector jobs on his side of the border. He's refused to craft a side deal on autos and has plainly said he'll increase tariffs until it makes no economic sense for Canada to build cars. This week on "It's Political" we look at whether the auto industry is worth saving, and how it could be propped up – despite the uncertainty Trump creates. Then, we'll shift gear and talk about uncertainty of a different kind. In Alberta, this week, the UCP government invoked the notwithstanding clause to end a three-week teacher strike. What's behind the move? We'll talk to the Alberta Federation of Labour which is trying to organize a potential general strike, and a constitutional lawyer about the greater meaning and consequence of Alberta's decision. In this episode: 3:23 — Saving the auto sector with Unifor Local 200 President John D'Agnolo, Former Toyota Canada executive Stephen Beatty, Centre for Future Work Director Jim Stanford, and Western University's Trillium Network for Advanced Manufacturing's Managing Director Brendan Sweeney. 41:33 — The fight against Alberta's use of the notwithstanding clause with Alberta Federation of Labour President Gil McGowan 55:48 — Why the debate over the notwithstanding clause matters with Conway Litigation Partner and constitutional lawyer Marion Sandilands. "It's Political" is produced by Althia Raj and Kevin Sexton. Our sound engineer is Matt Hearn. Our theme music is by Isaac Joel. Some of the audio clips this week were sourced from ParlVu, CPAC, the Legislative Assembly of Alberta, the Alberta Federation of Labour's Facebook page, CTV, Global, CP24, CBC, 10 Tampa Bay, Fox News, and the Manitoba Museum. Listen here and follow or subscribe at Apple Podcasts, Spotify, Amazon Music, or wherever you listen to your favourite podcasts.

It's YOUR time to #EdUpPCO In this episode, YOUR guest is Maris Spies, Co-Founder for HolonIQ and Chief Innovation Officer at QS. YOUR host is Amrit Ahluwalia⁠⁠, Executive Director of Continuing Studies at Western University in London, Ontario, Canada.Some key questions we tackle:·      How universities are responding to increasing student demand for clearer connections from education to the labour market·      What role PCO units can play in supporting lifelong labour market competitiveness for a university's students and alumni·      How the tech sector is evolving to ensure universities are able to support the delivery of this component of their mission at scaleListen in to #EdUp! Thank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Join YOUR EdUp community at ⁠⁠⁠⁠The EdUp Experience⁠⁠⁠⁠!We make education YOUR business!

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Adams, MD Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment options are available. Tune in to hear Dr. Peter Buch and Dr. Paul Adams, Professor in the Division of Gastroenterology at the Western University in London, Canada, discuss the latest on hemochromatosis.

Kate Reynolds , also known as the Lavender Librarian, is the founder and director of Storytime Solidarity. Based in Ontario, Canada, Kate has been working in public libraries since 2010. She is also a sought after international keynote speaker, trained opera singer, patient advocate, writer, and content creator with a large social media following. Kate's international advocacy has brought her to high-level events in Sweden, Hungary, Canada, and the United States. Kate holds masters degrees in musicology and library science at Western University as well as a bachelor of music in vocal performance at the University of Windsor. Openly disabled and autistic, Kate is working to make the world a kinder place, one storytime at a time.Learn more on our WebsiteSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Your stories with James Walsh, features writer with New York Magazine and author of "Everyone Is Cheating Their Way Through College." We also hear about the work of Mark Daley, chief artificial intelligence officer at Western University.

Support the show to get full episodes, full archive, and join the Discord community. Vicente Raja is a research fellow at University of Murcia in Spain, where he is also part of the Minimal Intelligence Lab run by Paco Cavo, where they study plant behavior, and he is external affiliate faculty of the Rotman Institute of Philosophy at Western University. He is a philosopher, and he is a cognitive scientist, and he specializes in applying concepts from ecological psychology to understand how brains, and organisms, including plants, get about in the world. We talk about many facets of his research, both philosophical and scientific, and maybe the best way to describe the conversation is a tour among many of the concepts in ecological psychology - like affordances, ecological information, direct perception, and resonance, and how those concepts do and don't, and should or shouldn't, contribute to our understanding of brains and minds. We also discuss Vicente's use of the term motif to describe scientific concepts that allow different researches to study roughly the same things even though they have different definitions for those things, and toward the end we touch on his work studying plant behavior. MINT Lab. Book: Ecological psychology Related papers In search for an alternative to the computer metaphor of the mind and brain Embodiment and cognitive neuroscience: the forgotten tales. The motifs of radical embodied neuroscience The Dynamics of Plant Nutation Ecological Resonance Is Reflected in Human Brain Activity Affordances are for life (and not just for maximizing reproductive fitness) Two species of realism Lots of previous guests and topics mentioned: BI 152 Michael L. Anderson: After Phrenology: Neural Reuse BI 190 Luis Favela: The Ecological Brain BI 191 Damian Kelty-Stephen: Fractal Turbulent Cascading Intelligence 0:00 - Intro 4:55 - Affordances and neuroscience 13:46 - Motifs 39:41- Reconciling neuroscience and ecological psychology 1:07:55 - Predictive processing 1:15:32 - Resonance 1:23:00 - Biggest holes in ecological psychology 1:29:50 - Plant cognition

This recording features audio versions of the November 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:ArticlesProspective Multicenter Observational Study of Silent Brain Infarction following Transradial Hepatic Intervention (The MOSAIC Study)First-in-Human Evaluation of a New Resorbable Microspherical Embolic Agent for Genicular Artery Embolization to Treat Pain Secondary to Knee OsteroarthritisImproved Outcomes from Prolonged Percutaneous Biliary Drainage in Pediatric Patients with Biliary Stenosis after Liver TransplantationComparison of Cone-Beam CT Angiography and Contrast-Enhanced CT Guidance Using Electromagnetic Navigation for Percutaneous Liver Microwave Ablation: A Retrospective Nonrandomized Observational StudyRemoval of Chest Ports for Infection: Risk in Patients with a History of Prior Port Removal for InfectionJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com.HostSonya Choe, University of California Riverside School of MedicineAudio EditorDaniel Roh, Loma Linda University School of Medicine Outreach CoordinatorMillennie Chen, University of California Riverside School of Medicine Abstract Readers:Shobhit Chamoli, Armed Forces Medical CollegeEmily Jagenberg, Oakland University. William Beaumont School of Medicine Ahmed Alzubaidi, Wayne State University School of MedicineIpek Midillioglu, Western University of Health Sciences, College of Osteopathic MedicineTiffany Nakla, Touro University Nevada College of Osteopathic Medicine, Nevada Support the show

In this illuminating episode of The Conscious Fertility Podcast, Dr. Lorne Brown speaks with Liz Grey, pelvic health physiotherapist and clinical director at Fringe, and Dr. Genevieve Newton, DC, PhD, nutritional scientist and scientific director at Fringe. Together, they explore how photobiomodulation (red and near-infrared light therapy) is revolutionizing women's health—from fertility and pelvic health to perimenopause, menopause, and skin rejuvenation. They unpack the science behind light therapy's effects on mitochondrial energy, blood flow, tissue healing, collagen production, and microbiome balance, while sharing practical insights and success stories from both clinical and research perspectives.Key takeaways:Light therapy boosts cell energy and blood flow, improving tissue health.It supports fertility and egg quality by enhancing mitochondrial function.The Fringe Pelvic Wand aids pelvic pain, dryness, and postpartum recovery.Red and infrared light promote collagen and healing; blue light helps infections.Safe, non-invasive, and easy to use at home for daily wellness.Liz Grey Bio:Liz Frey holds a BSc and BPHE from Queen's University, an MSc in Exercise Physiology from the University of Toronto, and an MSc (PT) from McMaster University. She later completed a third Master's in Clinical Science (Manipulative Therapy) at Western University and earned her FCAMPT designation, the highest level of orthopaedic manual therapy training. With additional certifications in medical acupuncture and IMS, Liz combines orthopaedic and pelvic health expertise to support women through pregnancy, postpartum, and menopause. As Pelvic Health Medical Director at Fringe, she integrates clinical care, education, and product development to empower women toward strength and wellness.Genevieve Newton Bio: Dr. Genevieve Newton, DC, PhD, spent nearly 20 years as a researcher and educator in nutritional science before becoming the Scientific Director at Fringe. Her role bridges research, product innovation, and education, ensuring the science behind Fringe's offerings is sound and evidence-based. A passionate advocate for holistic health, Genevieve focuses on the intersection of nutrition, physiology, and light therapy. She believes in healing body, mind, and spirit through the wisdom of nature and continues to make science accessible for practitioners and the public alike.You can purchase your own light mask and Pelvic Wands through Acubalance in Vancouver.Where To Find Liz Grey & Genevieve Newton: Website: https://fringeheals.com/ Education platform: https://www.fringe-u.com/ Emails:Liz - liz@fringeheals.comGenevieve - genevieve@fringeheals.com

What happens when a lost university student decides to go all-in on himself?In this inspiring conversation, Chris Thomson sits down with James Ward, a three-year Student Works Management Program veteran and newly appointed full-time coach, who went from feeling directionless at Western University to becoming one of the top-performing young entrepreneurs in the country.James reveals how he overcame rejection, mastered delegation, and turned discipline into leadership that now drives a $400K business. His story is a masterclass in ownership, consistency, and belief, and a reminder that success isn't about being special, it's about never stopping.Listen now because if you've ever doubted your potential or wondered what separates good from great, this episode delivers the roadmap. Don't miss it! Your next breakthrough could start here.About the GuestJames Ward is a three-year veteran of the Student Works Management Program and a graduate of Western University. Starting with no business background, he grew from a $100K rookie operator to a $400K top performer and Operator of the Year in the window cleaning division. Now stepping into his new role as a full-time coach, James is passionate about helping young entrepreneurs unlock their potential, lead with confidence, and create life-changing success.

On October 9, 1975, CBC listeners across the country heard David Suzuki introduce the very first episode of Quirks & Quarks. 50 years and thousands of interviews later, Quirks is still going strong, bringing wonders from the world of science to listeners, old and new.On October 7, 2025 we celebrated with an anniversary show in front of a live audience at the Perimeter Institute for Theoretical Physics in Waterloo, Ontario. We had guests from a range of scientific disciplines looking at what we've learned in the last 50 years, and hazarding some risky predictions about what the next half century could hold. Our panelists were:Evan Fraser, Director of Arrell Food Institute and Professor of Geography at the University of Guelph, co-chair of the Canadian Food Policy Advisory Council, a fellow of the Pierre Elliot Trudeau foundation, and a fellow of the Royal Canadian Geographical Society.Katie Mack, Hawking Chair in Cosmology and Science Communication at the Perimeter Institute for Theoretical Physics.Luke Stark, Assistant Professor in the Faculty of Information & Media Studies at Western University in London, Ontario, and a Canadian Institute for Advanced Research Azrieli Global Scholar with the Future Flourishing Program.Laura Tozer, Assistant Professor of Environmental Studies at the University of Toronto and director of the Climate Policy & Action Lab at the Department of Physical and Environmental Sciences at the University of Toronto Scarborough.Ana Luisa Trejos, a professor in the Department Electrical and Computer Engineering and the School of Biomedical Engineering and Canada Research chair in wearable mechatronics at Western University in London, Ontario.Yvonne Bombard, professor at the University of Toronto and scientist and Canada Research Chair at St. Michael's Hospital, Unity Health Toronto, where she directs the Genomics Health Services Research Program.

Send us a textWelcome back Rounds Table Listeners! This week, Dr. Mike Fralick sits down with Mihir Pandya, a third-year medical student at Western University. Mihir picks Mike's brain for advice on preparing for internal medicine clerkship: What's the best approach to acquire knowledge on the varying conditions seen in internal medicine? How can you foster better rapport with patients? What's the best way to ask your staff physician for a reference letter? Answers to these questions and more—here we go!Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Whether you work in a solo private practice, or a large health network, no doubt you're considering costs when it comes to deciding what to change and perhaps what to implement - or de-implement - in your practice. Perhaps you're in the position of making decisions on behalf of a health service or you are trying to quantify and communicate the costs and benefits of treatments you study in a research setting? Today is part 1 of a 2-part chat with Dr Codie Primeau about health economics in musculoskeletal rehabilitation, which has something for everyone working in health care. We're covering how to read a health economics analysis to decide whether the analysis can help you navigate the complex decisions you're grappling with. Dr Primeau is a physiotherapist and Assistant Professor in the School of Physical Therapy at Western University in London, Canada, and an Affiliate Scientist with Arthritis Research Canada. His research focuses on arthritis, chronic pain, and pelvic health, using a blend of qualitative and quantitative methods to improve patient care and outcomes, including health economics evaluation. ------------------------------ RESOURCES From whose perspective is cost-effectiveness judged?: https://pmc.ncbi.nlm.nih.gov/articles/PMC6351264/ Review of health economics evaluations in hip and knee orthopaedics: https://pubmed.ncbi.nlm.nih.gov/34262974/

Scientists detect for the first time an unknown source of GPS interference coming from space. Also, as AI begins to design more and more DNA sequences being manufactured synthetically, how can those manufacturers be sure that what their customers are asking for will not produce toxic proteins or lethal weapons? And… how camera traps in polish forests reveal that the big bad wolf is more scared of humans than anything else. For that last few years instances of deliberate jamming and interference of GNSS signals has become an expected feature of the wars the world is suffering. Yet this disruption of the signals that all of us use to navigate and tell the time nearly always emanate from devices on the ground, or maybe in the air. But in ongoing research reported recently by Todd Humphreys of University of Texas at Austin and colleagues around the world is beginning to reveal that since 2019 an intermittent yet powerful signal has been causing GPS failures across Europe and the North Atlantic. The episodes have been thankfully brief so far, but all the signs suggest it comes not from soldiers or aeroplanes, but from a distantly orbiting satellite somewhere over the Baltic Sea. It may not be malevolent, it could be a fault, but the net of suspicion is tightening. A team of scientists including some from Microsoft report today in a paper in the journal Science an investigation to try to strengthen the vetting of synthetic DNA requests around the world. As AI-designed sequencies increase in number and application, the factories that produce the bespoke DNA are in danger of making and supplying potentially dangerous sequences to customers with malicious intents. But how do you spot the bad proteins out of the almost infinite possible DNA recipes? Tessa Alexanian of the International Biosecurity and Biosafety Initiative for Science, and one of the authors explains some of the thinking. Finally, Liana Zanette of Western University in Ontario and colleagues have been hanging around in Polish forests scaring wolves. Why? Because as wolf numbers rise in protected reserves, more and more human-wolf interactions occur. And a suspicion has arisen that the legal protection they enjoy has led to them losing their fear of humans in a dangerous way. Not so, says Liana's team, blowing away the straw arguments and setting fire to the political motivation to reduce their protection status. Wolves are still terrified of Nature's apex predator – us. Presenter: Roland Pease Producer: Alex Mansfield Production Coordinator: Jana Bennett-Holesworth (Image: Simulation screen showing various flights for transportation and passengers. Credit: Oundum via Getty Images).

High tibial osteotomy (HTO) is a limb realignment surgery which is intended for people who have medial compartment osteoarthritis (OA), but are not suitable candidates for total knee replacement due to younger age, less severe disease and greater physical demands. The aim of HTO is to correct alignment, thereby shifting load away from the more involved knee compartment and limit progression of knee OA.On this week's episode of Joint Action, we are joined by Dr Trevor Birmingham and Dr David Parker to discuss high tibial osteotomy surgery, who it is suitable for and the risks involved.Professor Trevor Birmingham is a physiotherapist and Canada Research Chair in Musculoskeletal Rehabilitation at the University of Western Ontario in London, Canada. He leads research on musculoskeletal health, often combining clinical outcomes with biomechanical, imaging and biological measures in cohort studies and randomized trials. He co-directs the Wolf Orthopaedic Biomechanics Lab at the Fowler Kennedy Sport Medicine Clinic and is a founding member of the Bone and Joint Institute and the Collaborative Graduate Training Program in Musculoskeletal Health Research at Western University. Dr David Parker is an experienced orthopaedic knee specialist and co-founder of the Sydney Orthopaedic Research Institute (SORI). He is passionate about sport and is actively involved with international orthopaedic and sports medicine organisations and has extensive experience with athletes of all levels from recreational to elite. Dr Parker has authored over 100 peer-reviewed publications and many textbook chapters and has been awarded the Australian Orthopaedic Association Prize for Research. RESOURCESJournal articlesTotal knee replacement after high tibial osteotomy: time-to-event analysis and predictorsCONNECT WITH USJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

This recording features audio versions of the October 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:ArticlesEffectiveness of Transjugular Intrahepatic Portosystemic Shunt Creation for the Treatment of Hepatopulmonary Syndrome ReadAdverse Events of Tunneled Central Venous Catheters versus Totally Implantable Venous Access Devices in Pediatric Oncology: A Systematic Review and Meta-analysis ReadGenicular Artery Embolization Using Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Prospective Study ReadThe Impact of Common-to-External Iliac Arterial Diameter Ratio on Mid- to Long-term Patency of Kissing Aortoiliac Stents ReadPrediction of Recurrence of Hepatocellular Carcinoma Following Radiation Segmentectomy with Resin Microspheres Based on Underdosed Tumor Volume on Yttrium-90 Positron Emission Tomography/CT Dosimetry ReadUndertreated Volume and Tumor Morphology as Predictors of Outcome Following Thermal Ablation of 3–7-cm Hepatocellular Carcinoma ReadRadiofrequency Ablation in the Management of Extensive Multinodular Goiter: A Midterm Single-Center Experience ReadJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com. HostSonya Choe, University of California Riverside School of MedicineAudio EditorSonya Choe, University of California Riverside School of Medicine Outreach CoordinatorMillennie Chen, University of California Riverside School of Medicine Abstract Readers:Tiffany Nakla, Touro University Nevada College of Osteopathic Medicine, NevadaEmily Jagenberg, Oakland University. William Beaumont School of Medicine Ahmed Alzubaidi, Wayne State University School of MedicineClare Necas, Western University of Health SciencesMeghna Kolli, University of California Riverside School of MedicineSelena Yao, Wright State University Boonshoft School of MedicineShobhit Chamoli, Armed Forces Medical CollegeRead more about interventional radiology in IR Quarterly magazine or SIR's Patient Center. Support the show

BUFFALO, NY - September 24, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on September 22, 2025, titled “Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma.” In this study, led by first author Jacob Haagsma and corresponding author Trevor G. Shepherd from the Verspeeten Family Cancer Centre and Western University, Canada, researchers investigated how the loss of Trp53 – a critical tumor suppressor gene – affects immune responses in ovarian cancer. The team found that deleting Trp53 led to more aggressive tumor growth and a weaker immune response. These findings help explain why some ovarian tumors may be resistant to immunotherapy and point to new ways to improve treatment. High-grade serous ovarian carcinoma (HGSC) is a deadly cancer that is often diagnosed at a late stage. Immunotherapy, which enhances the body's immune system to fight cancer, has shown limited effectiveness in treating this type of cancer. To better understand why, the researchers developed a mouse model that closely mimics human HGSC. They injected ovarian epithelial cells, with and without Trp53, into the fallopian tubes, the origin site of most ovarian cancers. “In this study, we developed a syngeneic model reflecting both the site of origin and the genotype of early HGSC disease by deleting Trp53 in mouse oviductal epithelial (OVE) cells.” Mice injected with cells lacking Trp53 developed faster-growing and more invasive tumors, reflecting how the disease typically progresses in humans. These tumors also had fewer active T cells, which are immune cells responsible for attacking cancer. Moreover, the T cells that were present appeared less capable of responding to the tumor, creating an immune environment that allowed cancer to grow uncontrolled. Further analysis revealed that tumor cells without Trp53 had reduced activity in genes related to inflammation. These changes were associated with lower levels of key proteins that normally help immune cells detect and attack tumor cells. When the researchers collected tumor cells from the abdominal fluid of the mice—a condition that simulates advanced-stage disease—they observed even lower immune signaling than before. This suggests that as the tumor spreads, it becomes better at evading the immune system. This study highlights how early genetic mutations can shape the interaction between tumors and the immune system. In particular, the loss of Trp53 appears to trigger a chain of events that weakens immune surveillance and accelerates tumor progression. These findings emphasize the need to consider both genetic mutations and the tumor environment when designing immunotherapies for ovarian cancer. Understanding how genes like Trp53 influence immune behavior may lead to more effective treatments and help identify which patients are most likely to benefit from immunotherapy. DOI - https://doi.org/10.18632/oncotarget.28768 Correspondence to - Trevor G. Shepherd - tshephe6@uwo.ca Abstract video - https://www.youtube.com/watch?v=WFQw0psuC3M Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28768 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Canadian real estate investing is broken — the old playbook doesn't work anymore. In this new mini-series, I'm back after more than a year to cut through the noise and show you exactly what's changed, why Canada's market is stuck, and where the real opportunities are now.This series is all about why Canadian investors are increasingly pivoting to the U.S. With shrinking margins at home, mounting regulatory challenges, and disappearing cash flow, I'll show you how strategies like subject-to financing, double closes, and land flips south of the border create opportunities that simply don't exist in Canada. I'm diving deep into the deals I'm doing right now — real numbers, real strategies, and real results. From subject-to transactions to off-market acquisitions, I'll share how we're finding properties at steep discounts — sometimes 40 to 50 cents on the dollar — and why cash flow is still alive and well in the U.S. I'll also walk you through how to set up properly as a Canadian investor, avoid double taxation, and build a system that works even without setting foot on the properties. If you're a Canadian investor who's feeling stuck or frustrated, this series is for you. It's not as complicated as it looks once you know the playbook — and I'm here to share it. So make sure you're subscribed and stay tuned, because I'm just getting started.Disclaimer: This episode, as with every episode of this show, should NOT be considered as advice. Investment advice is NEVER given on this show. Always consult a competent investment advisor before making an investment decision.---Andrew Hines is a seasoned real estate investor, business-builder, educator, and podcast host, well-recognized for his extensive experience in the field. Andrew graduated with an HBA from the Richard Ivey School of Business in 2008 and spent three years teaching introductory business at Western University as a Lecturer. He has been investing in real estate since 2011 and completing value-add projects since 2015, primarily in the luxury student rental space. Andrew started a project management company for building out new-construction townhomes in 2016 and has since built over 50 residential units throughout Southwestern Ontario. Andrew is an advocate for treating real estate investing like a business and uses his experience in his educational endeavors, coaching numerous investors on strategies to achieve financial independence and scale their portfolios effectively.FOLLOW ON SOCIALS:Instagram: https://www.instagram.com/theandrewhinesFacebook: https://www.facebook.com/theandrewhinesTwitter: https://twitter.com/theandrewhinesLinkedIn: http://www.linkedin.com/in/theandrewhinesTikTok: https://www.tiktok.com/@therealandrewhines

It's YOUR time to #EdUpPCO In this episode, YOUR guest is Paul LeBlanc YOUR host is Amrit Ahluwalia⁠⁠, Executive Director of Continuing Studies at Western University in London, Ontario, Canada.Some key questions we tackle:·      How is the rapid evolution of AI technology transforming the nature of human-specific skills and work?·      What can universities do to help students keep pace with the changing labour market?·      How is the constant transformation in human-specific work impacting the need for continuous learning?Listen in to #EdUp! Thank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠ & ⁠⁠⁠⁠Dr. Joe Sallustio⁠⁠⁠⁠Join YOUR EdUp community at ⁠⁠⁠⁠The EdUp Experience⁠⁠⁠⁠!We make education YOUR business!

Dr. Al Grauer hosts. Dr. Albert D. Grauer ( @Nmcanopus ) is an observational asteroid hunting astronomer. Dr. Grauer retired from the University of Arkansas at Little Rock in 2006. travelersinthenight.org From April 2025. Today's 2 topics: - Greg Leonard was observing with our team's 60 inch telescope on Mt. Lemmon in Arizona when he discovered a relatively large space rock, 2017 FD157, which can theoretically come closer to the Earth's surface than the communications satellites! - Dr. Paul Wiegert of Western University in Canada, led a team of astronomers who have determined that 2015 BZ509, a 2 mile diameter object, bucks the solar system traffic by traveling in a direction backwards to all of the planets!   We've added a new way to donate to 365 Days of Astronomy to support editing, hosting, and production costs.  Just visit: https://www.patreon.com/365DaysOfAstronomy and donate as much as you can! Share the podcast with your friends and send the Patreon link to them too!  Every bit helps! Thank you! ------------------------------------ Do go visit http://www.redbubble.com/people/CosmoQuestX/shop for cool Astronomy Cast and CosmoQuest t-shirts, coffee mugs and other awesomeness! http://cosmoquest.org/Donate This show is made possible through your donations.  Thank you! (Haven't donated? It's not too late! Just click!) ------------------------------------ The 365 Days of Astronomy Podcast is produced by the Planetary Science Institute. http://www.psi.edu Visit us on the web at 365DaysOfAstronomy.org or email us at info@365DaysOfAstronomy.org.

Episode 203: Microinduction and harm reduction in OUD.  Nathan Bui and Sanjay Reddy describe how to manage opioid use disorder (OUD) by using microinduction and harm reduction, strategies that are reshaping the way we treat opioid use disorder. Written by Sanjay Reddy, OMSIV and Nathan Bui, OMSIV. Western University of Health Sciences, College of Osteopathic Medicine of the Pacific.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.IntroWelcome to episode 203 of Rio Bravo qWeek, your weekly dose of knowledge.Today, we're tackling one of the biggest health challenges of our time: opioid use disorder, or OUD. Nearly every community in America has been touched by it: families, friends, even healthcare providers themselves. For decades, treatment has been surrounded by barriers, painful withdrawals, stigma, and strict rules that often do more harm than good. Too many people who need help never make it past those walls. But here's the hopeful part, new approaches are rewriting the story. They are less about rigid rules and more about meeting people where they are. Two of the most promising strategies for treatment of OUD are buprenorphine microinduction and harm reduction. Let's learn why these two connected strategies could change the future of addiction recovery. Background information of treatment: The X-waiver (short for DATA 2000 waiver) was a special DEA requirement for prescribing buprenorphine for opioid use disorder. Doctors used to take extra training (8 hours) and apply for it. Then, they could prescribe buprenorphine to a very limited number of patients. The X-waiverhelped regulate buprenorphine but also created barriers to access treatment to OUD. It was eliminated in January 2023 and now all clinicians with a standard DEA registration no longer need a waiver to prescribe buprenorphine for OUD. Why buprenorphine?Buprenorphine is one of the safest and most effective medications for opioid use disorder. It has some key attributes that make it both therapeutic and extremely safe: 1) As a partial agonist at mu-opioid receptors, it binds and provides enough partial stimulation to prevent cravings and withdrawal symptoms without producing strong euphoria associated with full agonists. 2) Because it has a strong binding affinity compared to full agonists, it easily displaces other opioids that may be occupying the receptor. 3) As an antagonist at kappa-opioid receptors, it contributes to improved mood and reduced stress-induced cravings. 4) The “ceiling effect”: increasing the dosage past a certain point does not produce a stronger opioid effect. This ceiling effect reduces the risk of respiratory depression and overdose, making it a safer option than full agonists. 5) It also had mild analgesic effects, reducing pain. 6) Long duration of action: The strong binding affinity and slow dissociation from the mu-opioid receptor are responsible for buprenorphine's long half-life of 24–60 hours. This prolonged action allows for once-daily dosing in medication-assisted treatment for OUD. Induction vs microinduction:The problem is, starting it—what's called “induction”—can be really tough. Patients usually need to stop opioids and go through a period of withdrawal first. Drugs like fentanyl, which can cause precipitated withdrawal —a sudden, severe crash may push people back to using opioids. Because buprenorphine binds so tightly to the mu-opioid receptor, it can displace other opioids, such as heroin or methadone. If buprenorphine is taken while a person still has other opioids in their system, it can trigger sudden and severe withdrawal symptoms.Opioid withdrawal sign sand symptoms:Opioid withdrawal symptoms are very uncomfortable; patients may even get aggressive during withdrawals. As a provider, once you meet one of these patients you never forget how uncomfortable and nasty they can be. The symptoms are lacrimation or rhinorrhea, piloerection "goose flesh," myalgia, diarrhea, nausea/vomiting, pupillary dilation, photophobia, insomnia, autonomic hyperactivity (tachypnea, hyperreflexia, tachycardia, sweating, hypertension, hyperthermia), and yawning. Think about all the symptoms you run for COWS (Clinical Opiate Withdrawal Scale). It is estimated 85 % of opioid-using patients who inject drugs (PWID) reported opioid withdrawal. Fortunately, even though opioid withdrawal is very uncomfortable, it is not life-threatening (unlike alcohol or benzodiazepine withdrawal, which can be fatal).Many patients who start the journey treating opioid use disorder experience “bumps in the road” --they avoid treatment or drop out early. What is Microinduction? Microinduction is a fairly new strategy started in Switzerland around 2016. It is also known as the “Bernese method” (named after the city of Bern, Switzerland). With this method, instead of stopping opioids cold turkey, patients start with tiny doses of buprenorphine—fractions of a milligram. These doses gradually increase over several days while the patient continues their regular opioid use. While they begin this titer, they can continue use of the full agonist they were previously using–methadone, fentanyl, or heroin, while the buprenorphine begins to take effect. Once the buprenorphine builds up to a therapeutic level, the full agonist is stopped. This method uses buprenorphine's unique pharmacology to stabilize the brain's opioid system without triggering those really nasty withdrawal symptoms.Early studies and case reports suggest this is safe, tolerable, and effective method to do. Microinduction is changing the game, and it has been spreading quickly in North America. Instead of forcing patients to stop opioids completely, the dose is slowly increased over the next three to seven days, while the patient keeps using their usual opioids.By the end of that week, the buprenorphine has built up to a therapeutic level and the full agonist is stopped. The difference is really dramatic. Instead of a painful crash into withdrawal, patients describe the process as a gentle step down, or a ramp instead of a cliff. It's a flexible method. It can be done in a hospital, a clinic, or even outpatient with good follow-up. Once a patient and doctor develop a strong relationship built on the principles of patient autonomy and patient-centered care, microinduction can be closely monitored on a monthly basis including televisits. Microinduction has been shown to help more patients stay in treatment. The Role of Harm Reduction Instead of demanding perfection, harm reduction focuses on best practices providers can implement to reduce risk and keep patients safe. Harm reduction can vary from providing naloxone to reverse overdoses, giving out clean syringes, or offering safer injection education. It also means allowing patients to stay in treatment even if they keep using other substances, and tailoring care for groups like adolescents, parents, or people recently released from incarceration. Harm reduction says that instead of demanding perfection, let's focus on progress. Instead of all-or-nothing, let's devote resources to keeping people alive and safe. As mentioned,an option is providing naloxone kits so overdoses can be reversed in the moment. Also, giving out clean syringes so the risk of HIV or hepatitis infection is reduced while injecting heroin. Another way to reduce harm is teaching safer injection practices so people can protect themselves until they're ready for that next step in their treatment. It also means keeping the doors open, even when patients slip. If someone is still using other substances, they still deserve care. And it means tailoring support for groups who oftentimes get left behind. For people like adolescents, parents balancing childcare, or people coming out of incarceration who are at the highest risk of overdose. Harm reduction recognizes that recovery isn't a straight line. It's about meeting people where they are and walking with them forward. Conclusion:Microinduction is itself a harm reduction strategy. It lowers barriers by removing the need for painful withdrawal.When paired with a harm reduction culture in clinics, patients are more likely to enter care, stay engaged, and build trust with doctors for continued care. Managing opioid use disorder is one of the greatest health challenges of our time. But solutions like buprenorphine microinduction and harm reduction strategies are reshaping treatment—making it safer, more humane, and more accessible. If we embrace these approaches, we can turn barriers into bridges and help more people find recovery. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you. Send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Bluthenthal, R. N., Simpson, K., Ceasar, R. C., Zhao, J., Wenger, L., & Kral, A. H. (2020). Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug and Alcohol Dependence, volume 211, 1 June 2020, 107932. https://doi.org/10.1016/j.drugalcdep.2020.107932.De Aquino, J. P., Parida, S., & Sofuoglu, M. (2021). The pharmacology of buprenorphine microinduction for opioid use disorder. Clinical Drug Investigation, 41 (5), 425–436. https://doi.org/10.1007/s40261-021-01032-7. Taylor, J. L., Johnson, S., Cruz, R., Gray, J. R., Schiff, D., & Bagley, S. M. (2021). Integrating harm reduction into outpatient opioid use disorder treatment settings. Journal of General Internal Medicine, 36 (12), 3810–3819. https://doi.org/10.1007/s11606-021-06904-4.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Dr. Adam Power, co-founder and Chief Medical Officer at Front Line Medical Technologies, shares his fascinating journey from a background in vascular surgery to developing COBRA-OS, a groundbreaking device for hemorrhage control. He discusses the challenges and milestones in bringing this life-saving technology to market, the impact of the device in trauma and emergency care, and innovative future applications, including its unexpected use in non-traumatic cardiac arrest.    Guest links: https://frontlinemedtech.com/ Charity supported: Canadian Cancer Society Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 064 - Dr. Adam Power [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Dr. Adam Power. Dr. Power is a leader in innovative medical devices for trauma and emergency care that is committed to lowering the barriers and bleeding control and resuscitation. Dr. Power was instrumental in the development of COBRA-OS, drawing on his unique clinical viewpoint and expertise to ensure utmost patient safety and assist with the company's global expansion. In addition to his current role as co-founder and Chief Medical Officer at Front Line Medical Technologies Incorporated, Dr. Adam Power is a vascular surgeon in the division of vascular surgery at Western University, which he joined in the fall of 2012, and he is involved in all aspects of academics and clinical care. Also, Front Line was just named the 2025 Medical Device Technology Company of the Year, so I definitely wanted to highlight that too. All right. Well, thank you so much for being here today, Adam. I'm so delighted to speak with you. [00:01:55] Dr. Adam Power: Yes, it's a pleasure to be here. Thank you. [00:01:57] Lindsey Dinneen: Of course. Well, I'd love if you would start by sharing a little bit about yourself, your background, and what led you to what you're doing today. [00:02:05] Dr. Adam Power: Sure, I'd love to. So I'm a Canadian. I grew up on the east coast of Canada and was always interested in science and math and those types of things. I think, importantly, I grew up with an identical twin brother as well. So we really didn't know what we wanted to do with our lives, and ultimately we're good in science and math and ended up in medicine. And then both of us, when we got into medicine, we weren't sure exactly what we wanted to do in medicine, and ultimately both of us became surgeons. He became a urology surgeon, and I became a vascular surgeon, where we joke that we're both plumbers. I deal with the red stuff and he's the yellow stuff. But I did my initial medical school out on the east coast of Canada and then I did my general surgery training, which also involved trauma training, and then did a Master's of Bioscience Enterprise, which was basically biotech business from the University of Cambridge in the UK. When I finished my general surgery training, I continued on and did vascular surgery training at Mayo Clinic down in the US, and since that time after graduating from there, I've been at Western University in London, Ontario, Canada, for the past 13 years practicing as a vascular surgeon and an academic vascular surgeon. But when I was here at Western, I was always interested in innovation. I filed my first patent as a resident way back when, and have filed many over the years. But ultimately, if I was ever gonna see anything that came outta my head and was actually used in a patient or I could actually use in a patient, I figured I'd have to do it. I knew that I couldn't do it by myself. And so, I was very fortunate to meet my co-founder Dr. Asha Parekh. She's a PhD, biomedical engineer, extremely smart jack of all trades, and we teamed up now about eight years ago. We met here at Western, teamed up and really took an idea right out of our heads and patented it and raised money for it, prototyped it, brought it all through the regulatory steps to approvals, built a quality system and ultimately got it out onto the market in Canada, US, Europe, now Australia, and more to come. So the commercialization piece is what we've been focusing on over the past three years. And it's been really fun, but very exhausting but very rewarding as well. I think I'll stop there because I've been blathering on, but... [00:04:39] Lindsey Dinneen: No, it's fantastic. I really appreciate it. Plus, it's really fun to hear about your trajectory and so, okay, so you've teased us a little bit about this company of yours and this innovation of yours. Can you now share a little bit more about that and the development of it over time? [00:04:55] Dr. Adam Power: Yes, of course. Well, I mean, thing that we recognized early on is, and I'll just explain how I normally explain it, is if you have bleeding, it's a hemorrhage control device. And so if you have bleeding in your extremities, then you can often either put pressure on it or you can put a tourniquet on it. The problem when you have internal bleeding in the torso is that you can't actually put direct pressure on it, and there's no tourniquet that necessarily works for intraabdominal, intrathoracic bleeding. And when people bleed to death before coming to hospital, I mean, they're bleeding in these areas. You can empty almost your entire blood volume into your chest or into your abdomen. And this does account for a significant number of fatalities in all environments, basically in the trauma environment. That's military, that's pre-hospital, that's any time that that people are bleeding from internal organs. And so, because this is such a problem, the old fashioned way to fix it is to open up someone's chest and put a clamp on the aorta. So what does that do? Is it basically above the clamp, keeps blood flowing. The remaining blood in the body keeps blood flowing to the brain and the heart, keep you alive. And then below the clamp, it stops sort of the hemorrhaging from the spleen or the liver or whatever. So there's two things going on. One above the clamp and two below the clamp. But opening up somebody's chest in, you know, side of the road or in the emergency department really is impossible. You need highly skilled people like vascular surgeons like myself to be able to do this. And even if we were at the side of the road, we don't have the resources available to keep a patient alive. So there is this idea that we could do this minimally invasively, sort of accomplish this through minimally invasive means. And this, the idea of doing REBOA, which is an acronym-- Resuscitative Endovascular Balloon Occlusion of the Aorta-- came into being. This was probably 15, 20 years ago now. It wasn't necessarily a new idea. It had been done since the Korean War. There was somebody actually put a balloon up into someone's aorta to stop bleeding, but it came back again and was starting to be used a little bit more because. And so really the idea is to, through the femoral artery in your groin where you can feel a pulse, you introduce initially a sheath, which is your access point, and then you place the device up through the sheath, up into the aorta and inflate a balloon in the aorta. So instead of an external clamp, it's an internal balloon clamp that keeps blood flowing above the balloon and stops the blood flowing from below the balloon. Initially these devices were as big as my baby finger, like they were massive. And so if you put them in and you took it out, there was a big hole in the artery, had to cut down on the artery and repair the artery. But as it got more and more advanced and technology advanced, they become smaller and smaller. So that's really where we came in. The initial devices were 12 French, about the size of my baby finger. And then it advanced to Seven French and all of a sudden Seven French-- and these are diameter, French sizes are basically diameter-- and so when it went from 12 to seven French, now we could start doing it through the skin without actually cutting down on the artery. But that Seven French size was still very large and you're putting this in the hands of people that don't do this all the time. And so, we had the idea to bring it down even further now to Four French. And so this is essentially the size of an IV. And so you put a tiny little IV in somebody's femoral artery. And lots of different people can do that. And then you advance the device up in, inflate the balloon and you can magically occlude the aorta. In our first study that we did, the first inhuman study, we averaged about just over a minute to occlude someone's aorta, which was really fast to be able to get that amount of control that quickly. So that, that was really been the advancement is to decrease the access size, make this whole procedure simpler so that so that we can essentially save more lives. [00:09:08] Lindsey Dinneen: Okay, so thank you so much for sharing a little bit about that. Can you tell me about the beginnings of this innovation and how you brought it to market? Because it's really wonderful to hear all the success, and I'm so excited to hear that it's spreading, you have presence all over the place now. But you know, that's not an easy pathway. And I'm curious if you could walk us through a little bit about that decision to go, "You know what? We have a solution to a known problem, we can make this happen." And then how did you actually go about doing that? [00:09:42] Dr. Adam Power: Yeah. I think, I mean, I make it sound fairly straightforward, like a nice story, but it certainly was not that. I mean, we were very lucky I would say, that we had a lot of great advisors and mentors that we figured that we try not to fail early, fail fast. We wanted to make this one as successful as possible. So before we made any decision, we often would consult our mentors. And I'm a surgeon. I like to shoot first, ask questions later. My partner is not. And so I think we, we strike an excellent balance between not just the engineering and clinical side of things, but also from driving a business forward, getting all the information, but helping to get decisions made and moving forward. You know, starting out, we really had to choose the right sort of fit for what we wanted to pursue. We like to say it checked all the boxes. It checked all the boxes as far as even where we are. We're in Canada, we're not in a tech triangle where there's tons of funding opportunities. We knew we would be limited from a funding perspective, so we couldn't choose something that necessarily required a hundred million dollars to start up. So, you know, we had this device that we knew that we could fundraise for it. And then once it was fundraised, it was simple enough that we could get it manufactured. We chose to go the OEM route for the original equipment manufacturer, so we didn't have to build a manufacturing facilities ourselves. And then really from there, and building a quality system in the regulatory, we did work with a lot of consultants, that was both positive and negative experience. We had great consultants. We had not so great consultants. But really what our our goal was, is to learn the process ourselves. And so there's always manuals for things, even from the FDA perspective. They give out great documentation about what is supposed to go into an FDA application. And we dug into that. We really tried to understand. We did not trust anyone. That's one of my rules in surgery is, "don't trust anyone, not even myself." So we really didn't trust our consultants, and we tried to double check and triple check everything so that we didn't make mistakes. And of course, we did make mistakes and had to go back to the drawing board a few times. But as much as we wanted to get this out there, we really did wanna learn the process and know the process because ultimately we're the ones that are responsible to the patients in the end, and we needed to make sure that we had a handle on each and every step of the way. We, of course, because of that, were maybe not as quick as we could have been but in other places we became more efficient because, as we learned the process, getting feedback back and doing it right the first time, it really made a difference. So. [00:12:39] Lindsey Dinneen: Yeah, absolutely. Of course. Yeah, and I appreciate you going into a little bit more of the nitty gritty details 'cause it is so fun to hear the success stories, but of course, as you go along, there's that pathway to success. And it's helpful to understand that yeah, it's gonna be potentially a long road, sometimes windy, sometimes weird, but at the same time that it is possible. So as you look to the future with your company, what are you thinking of in terms of the future? Are you going to continue down this pathway and continue with iterations of this device? Are you thinking of new devices to introduce as well? Or, what are your thoughts for the future? [00:13:18] Dr. Adam Power: Yeah. And I have to be very careful what I say here, obviously. I can share generically what our thoughts are. We love this. Ultimately there was no better feeling than to use-- I mean, I've used my device to save a patient. And, you know, I would say that Asha, who's my co-founder, she cares. I'm a physician, but she cares about the patients just as much as I do, as does everyone in our company, which is really quite rewarding. But the future, what does the future hold? We really want this to get to everywhere. Yes, we're in lots of different countries ,have commercialized really all around the globe, but we really wanna go deeper into a lot of these geographies and really help as many people as possible. We realize that we can't do it on our own and are gonna need help. And so that's, we're in a growth phase right now of our company and we're looking for strategic collaboration. We're looking for those opportunities to deepen our ties and in all the different geographies. That being said, we are inventors and of course we have an idea every day about what we could improve on. But as far as the pipeline goes for our company, we are focusing on some very specific up and coming applications that we hope to have in the next couple of years. And I also wanna say that, I talked about trauma and bleeding, but the more exciting side of aortic occlusion has really been the applications. And you'd think, okay, it makes sense for trauma to be able to stop blood flow and stop bleeding. But some of our recent successes have been through postpartum hemorrhage. And there is this really, terrible condition called placenta accreta, where the placenta grows into the uterus and when you deliver the baby either by C-section or by delivery, and then the placenta attempts to be delivered, it tears, and you can have torrential bleeding. And, and so our device is being used in these women who are pregnant when inflicted with this condition and helping to decrease blood transfusions, helping to save a mother's life. So that's been really amazing. And then next on the horizon is strangely there's, it's not even a bleeding application. We've done some research and there's research going on globally about using aortic, minimally invasive aortic occlusion for non-traumatic cardiac arrest. And so if, which is really, again, it's like, "Oh my gosh, does this thing do everything? It might make your supper tonight if you're not careful." So it, so what happens there is that if somebody drops dead basically in front of you, and you start CPR, if you start pushing on their chest and pushing on their heart, you're pushing blood to the whole body. And the way you get someone back to life is if you can get the heart muscle oxygenated again. So if you put an aortic occlusion balloon up close to the heart, every time you push, you're directing blood right into the coronary arteries and right into the brain as well. And so what we're seeing is that there's increased return of spontaneous circulation rates when you do this with CPR. And there are different trials around the world that if this shows that there's an increase in survival or in better neurological survival, this will be the first time that we've really changed the script on cardiac arrest since advanced cardiac life support came out many years ago. So this, again, is very exciting for a simple device to be able to make that much impact in all these different areas. So, you know, we have a lot to focus on right now, even growing into the future because some of these, like cardiac arrest, are quite early on. So we don't wanna lose sight of this great original product, but we do think all the time about different pipeline ideas that could help other patients. [00:17:18] Lindsey Dinneen: Yeah, but, and to your point, even the amazing other use cases for this incredible device, like you said-- maybe it's gonna make us dinner next-- but the idea being that, who knows? I mean, there's so much more to discover even now, which makes me excited just to think about how many more use cases you could have for it and how many more people you could save. So, speaking of that, are there any stories that kind of stand out to you, moments that you've had where, you know, either through your day job, so to speak, being a vascular surgeon, but also being the co-founder of this company that really sort of affirmed to you that, "You know what? I am in the right place at the right time, in the right industry." Just those moments that really stick with you. [00:18:05] Dr. Adam Power: Yeah, I mean, it obviously all stems back to the patient and what patients are impacted. And I remember, the first time that the device was used at our hospital, one of the radiologists called me in and said, " We need to use one of these balloon occlusion devices for a patient that's been in an accident." And so I went in and I said, "I actually have the device that my partner and I created. We can use this for the patient." And so we started using it for the lady that was involved in a very serious accident, had a pelvic fracture, and she was a Jane Doe at that particular time. She was anonymous. And anyway, we noticed that she had actually had some vascular surgery done based on her angiograms, and I leaned over and I-- so she was sedated, but she was awake-- I said, "Have you had vascular surgery? Who's your vascular surgeon?" And she said, "It's Dr. Power. He's such a nice man." And so I was actually helping one of my patients. That was pretty crazy. [00:19:04] Lindsey Dinneen: Oh. [00:19:05] Dr. Adam Power: Also from my hospital, when I heard one of my junior residents was able to save someone's life. So, you know, junior residents are often good, but they're not trained surgeons. And so to have a simplistic device that one of my residents could actually place and help someone, that's pretty amazing too. There's also been times where like even the postpartum hemorrhage, we hear the first cases in the States of saving mother and baby. That's pretty incredible. Or that we donated some devices to the Ukraine conflict as well, and we heard that it saved some soldiers' lives as well. And there's different military groups that, that use our device and save soldiers. So it's all back to the patient. And hearing those success stories and hearing about somebody alive because of this particular device, because of all this effort that we've put in. I mean, it's really makes it worthwhile. It sounds kind of corny, but as a surgeon, I can help one person at a time, but as somebody involved in industry and medical device industry, I don't even have to be there. You know, this device can help long after I'm gone. The tricky part of it, being the Chief Medical Officer is, I usually only have to worry about my patients. Now I have to worry about everybody worldwide and the device being used. That was a little hard to wrap my head around initially, but yeah. [00:20:28] Lindsey Dinneen: Yeah, of course. But the ripple, the ripples, the impact that you get to have because of this device and because of your diligence getting it to market, because it isn't an easy path, and that's incredible. So thank you for doing the work that you're doing. That's not easy and it's very appreciated. This is incredible. So, yeah. So, okay. When you were growing up, let's say 8-year-old, Adam-- you know, you're having a good time doing whatever you like to do-- could you possibly have pictured yourself where you are now? [00:21:08] Dr. Adam Power: No, I don't think so. I mean, I, I. I came from a very small, like, small upbringing and, you know, in my family I had absolutely lovely family members, but they really, apart from my aunt, they weren't overly educated. And so I really didn't know what it took to be successful in life, really. I had work ethic from my parents, that's for sure. And so that's what they bred into me. And all I knew is that I was gonna work as hard as I could, and I figured that as long as I keep working-- and I was lucky to have some brains as well-- then I figured things would fall into place. They honestly haven't fallen into place exactly how I pictured them as I grew older and what it would look like. But I'm certainly thankful for where I am right now, and what is the next five years or 10 years gonna look like? I have no idea. And I guess I just don't even picture it. I have goals, but I also know that those goals change depending on circumstances. And you need, as I'm growing into middle age-- I think I'm beyond middle age now-- I'm thinking about midlife crisis and things like that. I get into philosophy and there's like telic and atelic things and so, it's sounds, again, it's about the path and the journey. It's not about the ultimate goal because, having reached a lot of these successes, that good feeling lasts for maybe a day or half a day. And you think you know, I spent all these years coming with the, with our device, getting our device to market and getting FDA approval and like, oh my gosh, like, you'd think, I'd feel so great about that. And it did. It felt great, but you wake up the next day and you gotta keep going. So you have to enjoy the journey and that's really what it's the wisdom that comes with age is trying to enjoy the journey as much as possible and not focus too much beyond that. [00:23:09] Lindsey Dinneen: Yeah. Yeah, and I think that's really good advice too, in that it is because the daily life isn't usually all the celebration and successes. I mean, that does happen and those are good moments, but because the vast majority of our life is spent on the journey component of it, and going through those peaks and valleys, it is important to find something you love and feel that you can make an impact in. So I'm so thankful that this is what you've chosen to do. So pivoting the conversation a little bit just for fun, imagine that you're to be offered a million dollars to teach a masterclass on anything you want. Could be within your industry, but it doesn't have to be. What would you choose to teach? [00:23:55] Dr. Adam Power: And would that mean that I was an expert in it? [00:23:58] Lindsey Dinneen: Well, certainly if you're getting paid a million dollars, somebody has decided you aren't an expert at it. How about that? [00:24:05] Dr. Adam Power: Okay. Well. Can I pretend like I'm an expert in it? There's something that I really love, but I'm not I'm probably not an expert in it. It would be, I would teach a masterclass in DJing. Isn't that strange? I know it's so random. [00:24:21] Lindsey Dinneen: Oh my goodness! Tell me more! [00:24:23] Dr. Adam Power: Well, I mean, I love music. I've, I grew up playing lots of sports and never was involved in music. And, and I've always appreciated music and art, but I was never able to do it. And, you know, growing up I did love sort of all types of music and then even electronic music and it just somehow talked to me. So I started DJing electronic music basically when I was around med school and have always loved it now, and when I was over in England, I DJ'ed on the campus radio and also DJ'd in a club. It was really fun and it sounds pretty silly to be talking about this when I have these other things that are on the go. But honestly, being able to share space with other human beings these days, and actually having a good time and having it not be stressful and having it be only, you know, everybody's wishing others to have a good time. There's not many people that go out sort of dancing into electronic music that are thinking bad things about other people. Really they're just out for a good time. And so being able to steer that whole music and scene is pretty awesome. And I do love it. And I don't DJ as much as I used to, but I still do different events, usually Christmas parties for the operating room. I'll do the typically wedding sort of DJ, but then they always, 'cause they know me, they let me do an hour long electronic set, which is like hardcore electronic. But then I go back to the regular stuff. But I would want to teach a masterclass in DJing. [00:25:56] Lindsey Dinneen: That is awesome. How exciting. Oh my gosh, I love that. And I think you're right. Music brings us together and it's a wonderful way to, to share a little bit of joy. [00:26:07] Dr. Adam Power: Yeah. [00:26:08] Lindsey Dinneen: Yeah. Okay. And then how do you wish to be remembered after you leave this world? [00:26:15] Dr. Adam Power: I, so number one is I don't, again, with my midlife crisis, I've actually been trying to eliminate my ego as much as possible. And so when people talk about legacy, it actually gives me the hives these days to be quite honest, because I don't like that because I think you're focused a lot on yourself. In my opinion, a lot of legacy is all about you. The way that I would wanna be remembered, though, is truly that I was kind and compassionate to everyone that I met, and that I stood for something, and that I left the world a better place. [00:26:57] Lindsey Dinneen: Yeah, those are wonderful things to want to be remembered for, absolutely. And then final question, what is one thing that makes you smile every time you see or think about it? [00:27:09] Dr. Adam Power: My kids. My son Kai and my daughter Saoirse. They are the light of my life. And I, you would think that with how busy I am ,you know, those things would deprioritize, but they truly are the one thing in my life that makes me smile when I get up in the morning. [00:27:30] Lindsey Dinneen: Oh, that's wonderful. Well, that is absolutely incredible. I loved getting to meet you and speak with you a little bit today. Thank you so much for sharing about your journey. Thank you for sharing about your incredible device and your bits of wisdom along the way. The idea of we've gotta enjoy the experience, the path, the journey. And I just really appreciate you spending some time with us. So thank you for everything you're doing to change lives for a better world. [00:27:59] Dr. Adam Power: Oh, well, thank you for giving me the opportunity to speak with you. It was absolutely lovely chatting with you today. [00:28:05] Lindsey Dinneen: Wonderful. Well, thank you again so much. Thank you also to listeners who are tuning in, and if you're as inspired as I am, I would love it if you would share this episode with a colleague or two and we'll catch you next time. [00:28:20] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Dr. Kate Moore grew up in Michigan but happily relocated to Southern California after gaining acceptance to Western University of Health Sciences. Since graduating in 2015, she has worked with exotics in several GPs, while learning acupuncture and laser therapy, until she opened her own house call practice in August of 2022.  Along with owning and operating Good Vibes Mobile Veterinary Services, she now also works as the primary veterinarian at the Santa Ana Zoo, where she promises NOT to steal any of the animals. Despite the workload, she also manages to find time to pursue her hobbies, some of which include sewing, watching football, painting D&D minis, kickboxing, going to Disneyland, taking her two rescue chihuahuas to the beach, and tending to her isopods. Topics covered in this episode:  Dr. Moore's journey into mobile house call practice Burnout and rediscovering passion Squirrel stories and wildlife care Understanding emotional processing & authenticity in veterinary practice The joy of snails Starting a mobile veterinary practice The House Call Vet Academy experience Links & Resources:  Visit the Good Vibes Mobile Veterinary Services website to learn more Find Dr. Moore on Instagram Find Dr. Moore on Facebook The House Call Vet Academy Resources:  Download Dr. Eve's FREE House Call & Mobile Vet Biz Plan Find out about the House Call Vet Academy online CE course Learn more about Dr. Eve Harrison Learn more about the Concierge Vet Mastermind Get your FREE Concierge Vet Starter Kit mini course Learn more about SoulShine Space For Vets. Use discount code SHINE15 for 15% OFF SoulShine Space For Vets! (Available for a limited time only! Rules and restrictions apply.) Learn more about 1-to-1 coaching for current & prospective house call & mobile vets Get House Call Vet swag Learn more about the House Call & Mobile Vet Virtual Conference Register TODAY for the House Call & Mobile Vet Virtual Conference, February 7th-8th, 2026!!!!!! Here's a special gift from me as a huge thank you for being a part of our wonderful House Call Vet Cafe podcast community! ☕️ GET 20% OFF your Four Sigmatic Mushroom Coffee when you order through this link! 4Sig truly is my favorite!!! Enjoy it in good health, my friends! Music:  In loving memory of Dr. Steve Weinberg.  Intro and outro guitar music was written, performed, and recorded by house call veterinarian Dr. Steve Weinberg.  Thank you to our sponsors!  Chronos  O3 Vets  This podcast is also available in video on our House Call Vet Cafe YouTube channel 

Send us a textMeet Dr. Ken Thai, PharmD—CEO of 986 Degrees Corporation (a pharmacy franchise), multi-site independent pharmacy owner across Southern California and Nevada, and Adjunct Assistant Professor of Pharmacy Practice at USC and Western University. A past president of CPhA (California Pharmacists Association) and current national VP at NCPA, he was honored with the 2022 NCPA Willard B. Simmons Independent Pharmacist of the Year. His career blends leadership, education, and entrepreneurship, always anchored to better patient care.In this conversation, we trace his path from a UCLA biology degree to a USC School of Pharmacy PharmD, followed by a Community Pharmacy Practice residency at USC. We dig into how he opened and scaled multiple independents—spanning long-term care, compounding, DME, infusion, and specialty—and why he built a franchise model to mentor and multiply pharmacist-owners. You'll hear how he designs training that sticks, builds culture across locations, and keeps teams focused on outcomes.We also talk about teaching and precepting: what pharmacy students need now, the mindset shift from clinician to owner, and practical steps to evaluate a market, choose services, and launch sustainably. Dr. Thai shares playbooks on onboarding, metrics that matter, quality systems, and how associations like CPhA and NCPA shape the future of independent pharmacy and pharmacy entrepreneurship.If you're a pharmacy student, new grad, independent owner, or healthcare entrepreneur, this episode is your blueprint for growth. Drop your questions in the comments, share with a colleague who's thinking about ownership, and subscribe for more SGV stories at the intersection of leadership, small business, and patient care. Keywords: independent pharmacy, pharmacy franchise, pharmacy ownership, pharmacy management, USC School of Pharmacy, Western University of Health Sciences, CPhA, NCPA, 986 Degrees, pharmacy entrepreneur.__________Music CreditsIntroEuphoria in the San Gabriel Valley, Yone OGStingerScarlet Fire (Sting), Otis McDonald, YouTube Audio LibraryOutroEuphoria in the San Gabriel Valley, Yone OG__________________My SGV Podcast:Website: www.mysgv.netNewsletter: Beyond the MicPatreon: MySGV Podcastinfo@sgvmasterkey.com

It's YOUR time to #EdUpPCO In this episode, YOUR guest is Shawn Miller YOUR host is Amrit Ahluwalia⁠⁠, Executive Director of Continuing Studies at Western University in London, Ontario, Canada.Some key questions we tackle:·      What are some of the top-of-mind considerations for onlinelearning leaders when thinking about the effective use of AI in education?·      How does our thinking around assessment need to evolve now that AI is so prevalent and accessible?·      What are some of the most common misconceptions higher ed faculty and leaders have about AI?Listen in to #EdUp! ThankYOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠ & ⁠⁠⁠⁠Dr. Joe Sallustio⁠⁠⁠⁠Join YOUR EdUp community at ⁠⁠⁠⁠The EdUp Experience⁠⁠⁠⁠!We make education YOUR business!

The name Terry Fox is synonymous with courage, perseverance and promise. After losing his leg at just 18 years old, his run across Canada inspired generations to come – and to date, has raised over $900 million for cancer research. His journey was deeply rooted in wanting to do more, by raising awareness and to help others see strength, not weakness. These same sentiments were true for George Hincks and Marshall McDougall, two Canadian men who both had a leg amputated as a result of injuries sustained in World War I. Their hike across our nation is a story you may not have heard - but once you do, you will never forget.Host Melanie Ng speaks with Eric Story, the author of a feature about George Hincks and Marshall McDougall. Eric is an adjunct professor at Wilfrid Laurier University and a postdoctoral fellow at Western University. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or @thebigstoryfpn on Twitter

Did you know that the questions we ask children should change as they develop? Asking the right questions at the right time helps children's communication flourish.Paula LaSala-Filangeri is a Speech-Language Pathologist who has been supporting children and families for over 25 years.How can parents move beyond flashcards and start turning everyday routines, like walking in nature or baking a cake, into powerful opportunities for language growth?Here are a few of the key insights we'll explore:

Every summer, Canadian scientists leave their labs and classrooms and fan out across the planet to do research in the field. This week, we're sharing some of their adventures.Camping out on a remote island with thousands of screaming, pooping, barfing birdsAbby Eaton and Flynn O'Dacre spent their summer on Middleton Island, a remote, uninhabited island that lies 130 kilometers off the coast of Alaska. They were there to study seabirds, in particular the rhinoceros auklet and the black-legged kittiwake, as a part of a long-term research project that monitors the health of the birds to help understand the health of the world's oceans. Eaton and O'Dacre are graduate students working under Emily Choy at McMaster University in Hamilton, OntarioDodging lions and mongooses to monitor what wild dogs are eating in MozambiquePhD student Nick Wright spent his summer in Gorongosa National Park in Mozambique. After a brutal civil war wiped out 95 per cent of the large mammals in the park, much work has been done to bring back a healthy wildlife population, to mixed success. Nick was monitoring wild dogs this summer to learn what they're eating, and what effects their recent re-introduction has had on the other animals. Wright is in the Gaynor lab at the University of British Columbia.Saving ancient silk road graffiti from dam-inundationThe legendary silk road is a network of trade routes stretching from Eastern China to Europe and Africa, used by traders from the second century BCE to the fifteenth century CE. Travelers often left their marks, in the form of graffiti and other markings on stone surfaces along the route. Construction of a dam in Pakistan is threatening some of these petroglyphs, and an international team is working to document them online while there is still time. Jason Neelis, of the Religion and Culture Department, and Ali Zaidi, from the Department of Global Studies, both at Wilfrid Laurier University in Waterloo, Ontario, are part of the team.Prospecting for World War II bombs in an Ottawa bogPablo Arzate's tests of sensor-equipped drones developed for mining uncovered 80-year-old relics leftover from World War II bomber pilot training in the Mer Bleue bog southeast of Ottawa. Arzate, the founder of 3XMAG Technologies from Carleton University, says his newly-developed technology revealed a trove of unexploded ordnance lurking beneath the bog's surface. Technology allows examination of Inca mummies without disturbing themAndrew Nelson and his team spent the summer in Peru devising new methods of non-invasively scanning Peruvian mummies dating to the Inca period – so they can study them without unwrapping them. In Peru, ancient human remains were wrapped in large bundles along with other objects. Nelson is a professor and chair of the Department of Anthropology at Western University in London, Ontario. This work is done in conjunction with the Ministry of Culture of Peru.Eavesdropping on chatty snapping turtles in Algonquin ParkSince 1972, scientists have been spending their summers at the Algonquin Park research station to monitor the turtles living in the area. In recent years, the researchers discovered that these turtles vocalise –– both as adults, and as hatchlings still in the egg. So this summer, Njal Rollinson and his students set out to record these vocalisations to try and understand what the turtles are saying. Rollinson is an associate professor in the Department of Ecology and Evolutionary Biology and the School of the Environment at the University of Toronto.

Welcome to another powerful episode of Resiliency Radio with Dr. Jill Carnahan, featuring integrative medicine expert Dr. Pejman Katiraei. In this conversation, we dive deep into the connections between Autism, mold exposure, and the microbiome, and how these factors influence overall health and chronic conditions.

Despite weeks of whirlwind American diplomacy, Russia sent wave after wave of drones and missiles across Kyiv and other cities on Thursday.It was the fiercest attack on the Ukrainian capital since President Donald Trump and Russian President Vladimir Putin met two weeks ago in Alaska, and the clearest indication yet of the Kremlin's resolve to continue its bombardment of Ukraine, leaving the two sides no closer to securing a diplomatic off-ramp.Host Caryn Ceolin speaks with Oleksa Drachewych, an assistant professor of history at Western University, about the challenges in forging a lasting peace in the largest land war in Europe since World War II. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or @thebigstoryfpn on Twitter

Ontario Premier Doug Ford says he'll crack down on labs using cats and dogs in experiments after revelations that beagles were subjected to heart attack studies at St. Joseph's Health Care in London, Ontario. The case has ignited debate over the role of animals in science. We hear from animal bioethicist Andrew Fenton, Western University researcher Arthur Brown, and Executive Director of the Canadian Centre for Alternatives to Animal Methods, Charu Chandrasekera, who advocates for replacing animal testing with new technologies.

In this episode, we speak with Rob Arntfield MD, the emergency medicine and critical care physician who founded Deep Breathe, an AI company whose technology actually surpassed doctors in COVID-19 lung ultrasound diagnosis. Rob shares his journey of merging computer science roots with medical expertise during the pandemic to create breakthrough diagnostic technology. Rob is a self-described "acutivist" working as an emergency medicine and critical care physician at London Health Sciences Centre. He serves as Professor of Medicine at Western University and co-authored the textbook Point-of-Care Ultrasound. Website: https://www.deepbreathe.ai/ If you enjoy the show, please leave a ⭐⭐⭐⭐⭐ rating on Apple or a

Recently, US Secretary of State Marco Rubio imposed sanctions on the UN Special Rapporteur on the Occupied Palestinian Territories, Francesca Albanese, saying, “The United States has repeatedly condemned and objected to biased and malicious activities of Albanese that have long made her unfit for service as a Special Rapporteur.”  Today we are joined by three of Albanese's predecessors—John Dugard, Richard Falk, and Michael Lynk, who talk about what these sanctions mean. They trace the United States' and Israel's longstanding attacks on not only Special Rapporteurs on Palestine, but the very claims to Palestinian rights. This latest instance is a particularly egregious attack on the UN and international law. We end with a plea to the international community to come to the aid of the Palestinian people, who are suffering famine, disease, and warfare of immense proportions.John Dugard SC, Emeritus Professor of Law, Universities of the Witwatersrand and Leiden; Member of Institut de Droit International; ; Director of Lauterpacht Centre for International Law, Cambridge (1995-1997); Judge ad hoc  International Court of Justice (2000-2018); Member of UN International Law Commission (1997 -2011); UN Special Rapporteur on Situation of Human Rights in Occupied Palestinian Territory (2001-2008); Legal Counsel, South Africa v Israel (Genocide Convention).Richard Falk is Albert G. Milbank Professor Emeritus of International Law at Princeton University (1961-2001) and Chair of Global Law, Faculty of Law, Queen Mary University London. Since 2002 has been a Research Fellow at the Orfalea Center of Global and International Studies at the University of California, Santa Barbara. Between 2008 and 2014 he served as UN Special Rapporteur on Israeli Violations of Human Rights in Occupied Palestine.Falk has advocated and written widely about ‘nations' that are captive within existing states, including Palestine, Kashmir, Western Sahara, Catalonia, Dombas.Falk has been nominated for the Nobel Peace Prize several times since 2008.Michael Lynk was a member of the Faculty of Law, Western University, London, Ontario, Canada between 1999 and his retirement in 2022. He taught courses in labour, human rights, disability, constitutional and administrative law. He served as Associate Dean of the Faculty between 2008-11. He became Professor Emeritus in 2023.In March 2016, the United Nations Human Rights Council unanimously selected Professor Lynk for a six-year term as the 7th Special Rapporteur for the human rights situation in the Palestinian Territory occupied since 1967. He completed his term in April 2022.He has written about his UN experiences in a 2022 book co-authored with Richard Falk and John Dugard, two of his predecessors as UN special rapporteurs: Protecting Human Rights in Occupied Palestine: Working Through the United Nations (Clarity Press).Professor Lynk's academic scholarship and his United Nations reports have been cited by the Supreme Court of Canada, the International Court of Justice, the International Criminal Court and the United Nations General Assembly.